NEW YORK (GenomeWeb) – The New York Stem Cell Foundation has offered details on its $25 million project to automate the production of induced pluripotent stem cells (iPSCs) and create "populations-on-a-chip."

A paper in Nature Methods, published August 3, details the steps in the industrial-scale production of cells for NYSCF's Global Stem Cell array, a product that has already attracted numerous collaborators and could speed up research on genetic diseases and drug development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.